Table 4.

LAR of cancer incidence to an age of 89 y from 2012 in current study areas without consideration of a reduction factor for the migration of radiocesium

All solid cancersLeukemiaBreast cancer
LAR, %LAR, %LAR, %
Age in 2012, yAreaLifetime exposure, mSvMaleFemaleLifetime exposure, mSvMaleFemaleLifetime exposure, mSvFemale
1Kawauchi15.10.2510.37515.50.0120.00817.20.100
Tamano42.80.7121.06143.80.0330.02248.50.284
Haramachi25.70.4280.63826.30.0200.01329.20.171
LBR43.9231.760.710.516.29
10Kawauchi14.60.1970.28914.90.0080.00516.80.066
Tamano41.40.5560.81942.10.0240.01547.40.186
Haramachi24.90.3350.49225.30.0140.00928.50.112
LBR43.9631.760.670.486.28
20Kawauchi13.90.1450.20913.90.0060.00415.90.038
Tamano39.30.4100.59039.20.0180.01245.00.109
Haramachi23.60.2460.35523.60.0110.00727.10.065
LBR44.0231.750.630.456.29
  • Lifetime exposure doses were calculated using means for corresponding areas in 2012 with only physical decay of radiocesium (Table 3).